An Updated Review of Randomized Clinical Trials Testing the Improvement of Cognitive Function of Ginkgo biloba Extract in Healthy People and Alzheimer’s Patients

Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®

(2019) Nagaendran Kandiah et al.   CNS Neuroscience & Therapeutics

Studies of the Anti-amnesic Effects and Mechanisms of Single and Combined Use of Donepezil and Ginkgo Ketoester Tablet on Scopolamine-Induced Memory Impairment in Mice

(2019) Jing Zhang et al.   Oxidative Medicine and Cellular Longevity

A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward

(2019) Michaël E. Belloy et al.   NEURON

The Effects of APOE and ABCA7 on Cognitive Function and Alzheimer’s Disease Risk in African Americans: A Focused Mini Review

(2019) Chelsie N. Berg et al.   Frontiers in Human Neuroscience

Questions EMERGE as Biogen claims aducanumab turnaround

(2019) Robert Howard et al.   Nature Reviews Neurology

Estrés oxidativo, respuesta inmune, plasticidad sináptica y cognición en modelos transgénicos de la enfermedad de Alzheimer

(2019) P.C. Bello-Medina et al.   NEUROLOGIA

Protective effect of the standardized leaf extract of Ginkgo biloba (EGb761) against hypertension-induced renal injury in rats

(2018) Ahmed O. Abdel-Zaher et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Similar treatment outcomes with Ginkgo biloba extract EGb 761 and donepezil in Alzheimer’s dementia in very old age: A retrospective observational study

(2018) Michael Rapp et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types

(2018) Yuan-Ta Lin et al.   NEURON

The Ginkgo biloba extract (GbE) protects the kidney from damage produced by a single and low dose of carbon tetrachloride in adult male rats

(2017) R.M. Chávez-Morales et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Phytochemical Ginkgolide B Attenuates Amyloid-β1-42 Induced Oxidative Damage and Altered Cellular Responses in Human Neuroblastoma SH-SY5Y Cells

(2017) Iqbal Gill et al.   JOURNAL OF ALZHEIMERS DISEASE

EGb 761 Protects Cardiac Microvascular Endothelial Cells against Hypoxia/Reoxygenation Injury and Exerts Inhibitory Effect on the ATM Pathway

(2017) Chao Zhang et al.   JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY

YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2

(2017) Zheng-Yi Li et al.   Journal of Neuroinflammation

Neuroprotective effects of Ginkgo biloba extract and Ginkgolide B against oxygen–glucose deprivation/reoxygenation and glucose injury in a new in vitro multicellular network model

(2017) Xiaohan Yang et al.   Frontiers of Medicine

Herbal medicine for management of the behavioural and psychological symptoms of dementia (BPSD): A systematic review and meta-analysis

(2016) Anna J Hyde et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Ginkgolide B revamps neuroprotective role of apurinic/apyrimidinic endonuclease 1 and mitochondrial oxidative phosphorylation against Aβ25-35-induced neurotoxicity in human neuroblastoma cells

(2015) Navrattan Kaur et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Effects of Ginkgo biloba Extract EGb 761, Donepezil and their Combination on Central Cholinergic Function in Aged Rats

(2015) Christoph Stein et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Neuroprotective Effect of Ginkgolide B on Bupivacaine-Induced Apoptosis in SH-SY5Y Cells

(2013) Le Li et al.   Oxidative Medicine and Cellular Longevity

Ginkgo biloba Special Extract in Dementia with Neuropsychiatric Features

(2012) Oleksandr Napryeyenko et al.   ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH

Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg

(2012) Horst Herrschaft et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Efficacy and Tolerability of a Once Daily Formulation of Ginkgo biloba Extract EGb 761® in Alzheimer's Disease and Vascular Dementia: Results from a Randomised Controlled Trial

(2011) R. Ihl et al.   PHARMACOPSYCHIATRY

Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial

(2010) Ralf Ihl et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against β-amyloid peptide-induced toxicity in SH-SY5Y cells

(2009) Chun Shi et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Efficacy and tolerability of Ginkgo biloba extract EGb 761® by type of dementia: Analyses of a randomised controlled trial

(2009) Oleksandr Napryeyenko et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES